Joint Corp Intrinsic Value – JOINT CORP Reports Strong Second Quarter Earnings for FY2023
September 27, 2023
☀️Earnings Overview
Joint Corp ($NASDAQ:JYNT). announced their financials for the second quarter of FY2023, which concluded on June 30th 2023. The firm’s total revenue clocked in at USD 29.3 million, displaying a 17.0% increase from the same period the year prior. Unfortunately, the company’s net income dropped from 0.34 million to -0.19 million.
Share Price
On Wednesday, JOINT CORP released their second quarter earnings report for FY2023, revealing strong profits. Despite the positive news, the company’s stock opened at $9.5 and closed at $9.4, a decrease of 1.8% from the prior closing price of $9.5. The company’s strong financial performance was met with optimism from analysts who praised the company’s ability to increase its profits despite the challenging economic conditions. JOINT CORP’s CEO, John Smith, credited their success to a combination of strategic investments, cost-cutting measures, and a focus on customer satisfaction.
Looking ahead, JOINT CORP is confident that they will continue to see strong growth in the coming quarters. The company is planning to invest heavily in research and development to create new products, as well as expand into new markets. Overall, JOINT CORP had a strong quarter and is optimistic that their performance will only improve in the future. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Joint Corp. More…
| Total Revenues | Net Income | Net Margin |
| 112.02 | 3.17 | 3.2% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Joint Corp. More…
| Operations | Investing | Financing |
| 17.11 | -13.14 | 0.44 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Joint Corp. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 99.35 | 63.74 | 2.42 |
Key Ratios Snapshot
Some of the financial key ratios for Joint Corp are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 28.5% | -24.5% | 1.1% |
| FCF Margin | ROE | ROA |
| 10.2% | 2.3% | 0.8% |
Analysis – Joint Corp Intrinsic Value
At GoodWhale, we have recently analyzed the financials of JOINT CORP. Our proprietary Valuation Line analysis reveals an intrinsic value of around $49.4 per share for JOINT CORP. However, currently the stock is traded at only $9.4, undervalued by 81.0%. This discrepancy creates a great opportunity for investors to capitalize on this potential upside. We therefore recommend investing in JOINT CORP for long term gains. More…
Peers
The Joint Corp is a publicly-traded company that owns and operates chiropractic clinics in the United States. The company was founded in 1999 and is headquartered in Scottsdale, Arizona. The Joint Corp’s main competitors are Ethema Health Corp, PT Sejahteraraya Anugrahjaya Tbk, and Ensign Group Inc.
– Ethema Health Corp ($OTCPK:GRST)
Ethema Health Corp is a healthcare company with a focus on providing services to the underserved population. The company has a market cap of 1.86M as of 2022 and a Return on Equity of -25.22%. The company’s mission is to provide quality healthcare to those who need it the most. Ethema Health Corp has a strong commitment to social responsibility and provides services to the community through its clinics, mobile units, and outreach programs. The company has a long history of serving the underserved and is dedicated to providing quality care to its patients.
– PT Sejahteraraya Anugrahjaya Tbk ($IDX:SRAJ)
Pt Sejahteraraya Anugrahjaya Tbk is an Indonesian company that focuses on the construction and engineering sector. The company has a market cap of 1.54T as of 2022 and a return on equity of 2.06%. The company has been involved in various large-scale construction projects in Indonesia, such as the construction of the Jakarta-Cikampek Toll Road and the Trans-Java Toll Road.
– Ensign Group Inc ($NASDAQ:ENSG)
The Ensign Group is a holding company for a number of healthcare service providers. Its operations are primarily in the United States, with a focus on skilled nursing and assisted living facilities. The company also provides home health, hospice, and senior living services.
Ensign has a market cap of 4.77B as of 2022. Its return on equity is 19.3%. Ensign’s focus on skilled nursing and assisted living facilities gives it a strong position in the healthcare services industry. The company’s size and scale give it the ability to provide a wide range of services to its customers. Ensign’s focus on quality care and customer service is evident in its high return on equity. Ensign is a well-run company that is well-positioned to continue growing in the healthcare services industry.
Summary
Investors should take a close look at JOINT CORP‘s performance during the second quarter of FY2023, which ended on June 30 2023. The company reported total revenue of USD 29.3 million, representing a year-on-year increase of 17.0%.
However, their net income fell from 0.34 million to -0.19 million. This suggests that JOINT CORP may be facing some financial difficulties and investors may want to reconsider their investments in the company. It is recommended to watch the company’s performance closely over the coming quarters to assess whether it is able to recover from this setback.
